Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P11021 (
BiP
)
2,049
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Shiga-toxigenic Escherichia coli (STEC) infection causes severe bloody diarrhea, renal failure, and hemolytic uremic syndrome. Recent studies showed global increases in Locus for Enterocyte Effacement (LEE)-negative STEC infection. Some LEE-negative STEC produce Subtilase cytotoxin (SubAB), which cleaves endoplasmic reticulum (ER) chaperone protein
BiP
, inducing ER stress and apoptotic cell death. In this study, we report that SubAB induces expression of a novel form of
Lipocalin-2
(
LCN2
), and describe its biological activity and effects on apoptotic cell death. SubAB induced expression of a novel
LCN2
, which was regulated by PRKR-like endoplasmic reticulum kinase via the C/EBP homologous protein pathway. SubAB-induced novel-sized
LCN2
was not secreted into the culture supernatant. Increased intracellular iron level by addition of holo-transferrin or FeCl
3
suppressed SubAB-induced PARP cleavage. Normal-sized FLAG-tagged
LCN2
suppressed STEC growth, but this effect was not seen in the presence of SubAB- or tunicamycin-induced unglycosylated FLAG-tagged
LCN2
. Our study demonstrates that SubAB-induced novel-sized
LCN2
does not have anti-STEC activity, suggesting that SubAB plays a crucial role in the survival of LEE-negative STEC as well as inducing apoptosis of the host cells.
...
PMID:Subtilase cytotoxin induces a novel form of Lipocalin 2, which promotes Shiga-toxigenic Escherichia coli survival. 3314 18